Valuation dashboard for Electromed, Inc. (ELMD) with P/E 19.72, P/B 4.14, EV/EBITDA 13.83 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Analysis Summary
Electromed, Inc. reported revenue of $73.8M in the most recent fiscal year, growing at a 5-year CAGR of 15.6%. Net income reached $11.3M, with a 36.8% 5-year CAGR.
Trailing-twelve-month margins: gross margin 78.5%, operating margin 18.8%, net margin 15.3%.
At the current price of $26.15, ELMD trades at a P/E of 19.72 and an ROE of 23.38%. Market capitalisation stands at $217M.
Balance sheet quality for ELMD: current ratio of 4.7. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 19.72 |
| Price / Book | 4.14 |
| EV / EBITDA | 13.83 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $14.15 |
| vs Current Price | -45.9% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| ELMD | Electromed, Inc. | $217M | 19.72 | 4.14 | 23.4% |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 28.37 | 4.41 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $65.3B | 17.84 | 2.62 | 14.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $26.15 |
| Market Cap | $217M |
| Exchange | AMEX |
| Country | US |
Profitability
| Return on Equity | 23.38% |
| Return on Invested Capital | 20.19% |
| Return on Assets | 17.05% |
| Gross Margin | 78.54% |
| Operating Margin | 18.82% |
| Net Margin | 15.32% |
Related companies: CATX · HSDT · INFU · INGN · MXCT · NNOX · OM
Explore sector: Healthcare · Medical - Devices
More sections of ELMD: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks